風邪・咳・喉の痛み治療の世界市場

◆英語タイトル:Cold, Cough and Sore Throat Remedies Market: Oral Syrups Segment Will Remain the Most Attractive and Dominant Dosage Type Segment Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 – 2026
◆商品コード:DATA70609013
◆発行会社(調査会社):Future Market Insights
◆発行日:2017年3月
◆ページ数:224
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Individual PriceUSD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Corporate PriceUSD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The oral syrups segment is expected to dominate the global cold, cough and sore throat remedies market in the coming decade
Oral syrups segment is expected to expand at 2.9% CAGR over the estimated period and be valued more than US$ 10 Bn by the end of 2026. The segment is expected to create absolute $ opportunity of a little more than US$ 300 Mn in 2017 over 2016. The segment is the most acceptable dosage form for cough, cold, and sore throat medicines due to ease of administration and pleasant taste. The oral syrups segment dominated the global cold, cough and sore throat remedies market in terms of revenue in 2016 and the trend is projected to continue throughout the forecast period. Oral syrups segment is the most attractive segment, with attractiveness index of 1.5 over the forecast period.

Pleasant taste and easy intake of oral syrups are the key factors boosting segmental growth during the forecast period

The majority of paediatric and geriatric patients prefer liquid as a delivery method over solid dosage forms, which is attributed to high proportion of oral syrups in the global cold, cough and sore throat remedies market. There is large scale adoption of oral syrups by pharmacy chains, especially in European countries, which is expected to fuel the sales of oral syrups in the global market. Most of the oral syrups are OTC (Over-the-Counter) drugs which do not need a doctor’s prescription. Consumers are conditioned to treat cold, cough and sore throat with OTC drugs than to seek healthcare professionals and this propels the growth of the oral syrups segment across the globe. Continuous launch of new and improved drug types and increasing investment in research and development by manufacturers in oral syrups would lead to the growth of the oral syrups segment in the global cold, cough and sore throat remedies market. An intake of oral syrups is suitable for all patients irrespective of their age. Particularly, oral syrups are prescribed mostly for children and elderly patients and this factor is creating a positive impact on the oral syrups segment.

Emerging markets such as Brazil, Russia, India and China represent the larger market for OTCs and generics. Pharmaceuticals industry in these countries is dominated by the private sector, where pharma companies can reap larger revenue from the strong sales of oral syrups. The oral syrups segment is projected to grow in North America during 2016-2026

Oral syrups segment dominated the North America cold, cough and sore throat remedies market by doses type segment in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Oral syrups segment is the most attractive segment in the North America cold, cough and sore throat remedies market, with attractiveness index of 1.5 over the forecast period. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 1.9% over 2016–2026, to reach more than US$ 3,000 Mn by 2026. OTC cough syrups for children are receiving exceptional attention in the U.S. by regulators, physicians and parents due to safety concerns. In the last 3 years, FDA has withdrawn more than 200 cough syrups containing hydrocodone from the market.

In Latin America, revenue from the oral syrups segment is anticipated to increase at a CAGR of 3.6% over 2016–2026, to reach more than US$ 500 Mn by 2026. The segment is expected to record attractiveness index of 1.7 over the forecast period in Western Europe. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 4.1% over 2016–2026, to reach a market value of a little more than US$ 5,000 Mn by 2026 in the APEJ cold, cough and sore throat remedies market.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Global Cold, Cough and Sore Throat Market Analysis Scenario

3.3. Market Size (US$ Mn) and Forecast

3.3.1. Market Size and Y-o-Y Growth

3.3.2. Absolute $ Opportunity

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Regulatory Scenario

4.7.Product Differentiation by Dosage Form

4.8. STP Analysis

5. Global Cold, Cough and Sore Throat Market Analysis and Forecasts, By Drug Type

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Drug Type

5.3. Y-o-Y Growth Projections By Drug Type

5.4. Market Value Forecast By Drug Type, 2016–2026

5.4.1. Antihistamines

5.4.2. Expectorants

5.4.3. Bronchodilators

5.4.4. Decongestants

5.4.5. Antibiotics

5.4.6. Others

5.6. Market Attractiveness By Drug Type

6. Global Cold, Cough and Sore Throat Market Analysis and Forecasts, By Dosage Type

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Dosage Type

6.3. Y-o-Y Growth Projections By Dosage Type

6.4. Market Value Forecast By Dosage Type, 2016–2026

6.4.1. Oral Syrups

6.4.2. Tablets/Pills

6.4.3. Nasal Drops

6.4.4. Lozenges

6.4.5. Others

6.5. Market Attractiveness By Dosage Type

7. Global Cold, Cough and Sore Throat Market Analysis and Forecasts, By Distribution Channel

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Distribution Channel

7.3. Y-o-Y Growth Projections By Distribution Channel

7.4. Market Value Forecast By Distribution Channel, 2016–2026

7.4.1. Hospital Pharmacies

7.4.2. Retail Pharmacies

7.4.3. Drug Stores

7.4.4. Supermarkets/Hypermarkets

7.4.5. e-Commerce/Online Pharmacies

7.5. Market Attractiveness By Distribution Channel

8. Global Cold, Cough and Sore Throat Market Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value Forecast By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness By Region



★調査レポート[風邪・咳・喉の痛み治療の世界市場] (コード:DATA70609013)販売に関する免責事項を必ずご確認ください。
★調査レポート[風邪・咳・喉の痛み治療の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆